Literature DB >> 20394710

Impact of the routine varicella vaccination programme on varicella epidemiology in Germany.

A Siedler1, U Arndt.   

Abstract

Routine varicella vaccination with one dose for children of 11 to 14 months was recommended in Germany in 2004 to reduce disease incidence and severe complications. A country-wide varicella sentinel surveillance system was initiated in 2005 to detect trends of disease frequency and vaccine uptake and to evaluate the vaccination programme. A convenient sample of about 1,000 paediatricians and general practitioners was recruited to report on a monthly basis on varicella cases by age groups seen in their practice, and on varicella vaccine doses administered. Sentinel data from April 2005 to March 2009 show a reduction of 55% of varicella cases in all ages; 63% in the age group 0-4 years and 38% in 5-9-year-olds. The number of vaccine doses per reporting unit in all regions and physician groups increased during the same period. The number of reported cases as well as administered vaccines differed between physician groups and regions with different reimbursement policies. Where reimbursement was settled early and vaccine doses were increasing varicella cases started to decrease early as well. Besides reimbursement policies the availability and vaccination schedules influenced vaccine uptake. Sentinel surveillance provided valid data on trends for varicella associated morbidity, vaccine uptake and the age distribution of cases. The results confirm that following the introduction of routine varicella vaccination, varicella morbidity started to decline in Germany.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394710

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  27 in total

1.  Varicella vaccination coverage of children under two years of age in Germany.

Authors:  Annicka M Reuss; Marcel Feig; Lutz Kappelmayer; Anette Siedler; Tim Eckmanns; Gabriele Poggensee
Journal:  BMC Public Health       Date:  2010-08-19       Impact factor: 3.295

2.  Varicella vaccination programs do not seem to shift the age of disease to older age groups.

Authors:  Manuel García Cenoz
Journal:  Transl Pediatr       Date:  2014-10

Review 3.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

4.  Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.

Authors:  Anette Siedler; Marleen Dettmann
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.

Authors:  Kevin M Bakker; Micaela Elvira Martinez-Bakker; Barbara Helm; Tyler J Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

6.  Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.

Authors:  Sonja Thiele; Aljona Borschewski; Judit Küchler; Marc Bieberbach; Sebastian Voigt; Bernhard Ehlers
Journal:  Clin Vaccine Immunol       Date:  2011-05-11

7.  Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study.

Authors:  Ahmet Soysal; Erdem Gönüllü; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

Review 8.  Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses.

Authors:  Paolo Bonanni; Anne Gershon; Michael Gershon; Andrea Kulcsár; Vassiliki Papaevangelou; Bernard Rentier; Catherine Sadzot-Delvaux; Vytautas Usonis; Timo Vesikari; Catherine Weil-Olivier; Peter de Winter; Peter Wutzler
Journal:  Pediatr Infect Dis J       Date:  2013-07       Impact factor: 2.129

Review 9.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

10.  Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Authors:  Johannes Horn; André Karch; Oliver Damm; Mirjam E Kretzschmar; Anette Siedler; Bernhard Ultsch; Felix Weidemann; Ole Wichmann; Hartmut Hengel; Wolfgang Greiner; Rafael T Mikolajczyk
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.